Page 165 - ASHG 2012 Annual Meeting Program Guide

154
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
aggressive disease within Africa.
E. A. Tindall, M. S. R.
Bornman, S. van Zyl, D. C. Petersen, A. M. Segone, L. R.
Monare, P. A. Venter, V. M. Hayes.
1086
W Insulin-like growth factor biomarkers
and genetic polymorphisms are associated with
adenomatous polyp risk.
C. B. Vaughn, H. Ochs-Balcom,
J. Nie, Z. Chen, C. L. Thompson, L. Li.
1087
T An unusual
BRCA
mutation distribution in a high
risk cancer genetics clinic.
A. C. Nelson-Moseke, J. M.
Jeter, H. Cui, D. Roe, S. K. Chambers, C. M. Laukaitis.
1088
F Functional characterization of the pancreatic
cancer
TERT-CLPTM1L
risk locus on Chr5p15.33.
J. Jia,
A. Thompson, A. Bosley, H. Parikh, Z. Wang, I. Collins, G.
Petersen, C. Westlake, T. Andresson, L. Amundadottir.
1089
W A comprehensive approach to evaluating the
impact of sequence variants of uncertain significance
in 24 breast cancer genes on transcript splicing.
S.
Casadei, T. Walsh, C. H. Spurrell, A. M. Thornton, J. B.
Mandell, S. M. Stray, M. K. Lee, M. C. King.
1090
T Functional analysis of germline
TP53
mutations
in lymphocytes from Li-Fraumeni patients reveals a
drastic biological impact of missense mutations.
J.-M.
Flaman, Y. Zerdoumi, C. Durambure, J. Laury-Andas, G.
Bougeard-Denoyelle, T. Frebourg, French LFS Working
Group.
1091
F Investigation of the bladder cancer association
within
TP63
gene region.
Y.-P. Fu, I. Kohaar, J. Earl,
W. Tang, J. D. Figueroa, N. Malats, M. Garcia-Closas,
N. Chatterjee, M. Kogevinas, P. Porter-Gill, D. Baris, D.
Albanes, M. P. Purdue, A. Carrato, A. Tardón, C. Serra, R.
García-Closas, J. Lloreta, A. Johnson, M. Schwenn, M. R.
Karagas, A. Schned, W. R. Diver, S. M. Gapstur, M. Thun,
J. Virtamo, D. T. Silverman, N. Rothman, F. X. Real, L.
Prokunina-Olsson.
1092
W Genetic variant as a selection marker for anti-
PSCA immunotherapy of bladder cancer.
I. Kohaar,
P. Porter-Gill, P. Lenz, Y. P. Fu, A. Mumy, W. Tang, A. B.
Apolo, N. Rothman, D. Baris, A. R. Schned, K. Ylaya, M.
Schwenn, A. Johnson, M. Jones, M. Kida, D. T. Silverman,
S. M. Hewitt, L. E. Moore, L. Prokunina-Olsson.
1093
T Tumor microenvironment and genetic
association with colorectal cancer risk.
V. Peltekova, M.
Lemire, Q. Trinh, A. Qazi, R. Bielecki, L. Hodgson-Jensen,
D. D’Souza, S. Zandi, T. Chong, R. De Borja, L. Timms, J.
Rangrej, M. Volar, M. Chan-Seng-Yue, T. Beck, J. Kwan, K.
Kozak, C. Ash, L. D. Stein, J. E. Dick, J. D. McPherson, B.
W. Zanke, A. Pollett, S. Gallinger, T. H. Hudson.
1094
F Evaluation of the functional effects on cell
signaling caused by allelic forms of prostate stem cell
antigen.
P. Porter-Gill, A. Mumy, W. Tang, I. Kohaar, L.
Prokunina-Olsson.
1095
W Discovery and functional characterization of
somatic mutations in the novel tumor suppressor
DEAR1
.
J. Reuther, N. Chen, S. Balasenthil, A. Killary.
Houlston, M. Dunlop, I. Tomlinson, Colon Cancer Family
Registry, COGENT Consortium.
1073
F The combined effect of the functional variants
in cell death pathway genes on cervical cancer.
K.
Chattopadhyay, C. Dandara, A. Hazra, A. L. Williamson.
1074
W Genetic ancestry is associated to changes in
DNA repair capacity in non-melanoma skin cancer
patients from Puerto Rico.
H. J. Diaz-Zabala, L. Morales,
J. Matta, J. Dutil.
1075
T Genetic ancestry and breast cancer survival in
U.S.
Latinas. L. Fejerman, D. Hu, S. Huntsman, C. Eng, E.
Gonzalez Burchard, E. M. John, M. C. Stern, E. Perez-
Stable, E. Ziv.
1076
F Genetic polymorphisms in candidate
inflammation-related genes and risk of esophageal
squamous cell carcinoma.
A. Golozar, T. Beaty, P. Gravitt,
I. Ruczinski, Y. L. Qiao, J. H. Fan, T. Ding, Z. Z. Tang, A.
Etemadi, N. Hu, S. M. Dawsey, N. D. Freedman, C. C.
Abnet, A. Goldstein, P. R. Taylor.
1077
W Frequency of VNTR polymorphism in IL-1Ra
gene in colorectal cancer.
I. A. Gutíerrez, E. Cortes, A. M.
Puebla, M. P. Gallegos.
1078
T Individual ancestry influences the gene
expression profile in breast cancer patients of admixed
populations.
D. Hu, E. Ziv.
1079
F Risks of colorectal and other cancers following
endometrial cancer in Lynch syndrome.
M. A. Jenkins,
N. M. Lindor, R. W. Haile, P. A. Newcomb, L. Le Marchand,
S. Gallinger, J. L. Hopper, A. K. Win.
1080
W Prevalence and clinical features of
HOXB13
mutation carriers in prostate cancer patients from
Germany.
C. Maier, J. Xu, S. L. Zheng, M. Luedeke, A. E.
Rinckleb, W. Vogel, S. N. Thibodeau, K. A. Cooney, W. B.
Isaacs on behalf of ICPCG.
1081
T Histologic types and risk factors in familial lung
cancer cases from Southern Louisiana.
D. Mandal,
M. Haskins, A. Bencaz, J. Hutchinson, J. Chambliss, H.
Rothschild, J. E. Bailey-Wilson.
1082
F Using an 18 locus genotype to predict risk of
breast cancer, and the relationship between age,
estrogen receptor status and genetic risk.
C. Merrick,
C. Purdie, L. Jordan, C. Palmer, R. Tavendale, A. Ashfield,
P. Quinlan, P. Armory, A. Thompson, J. Berg.
1083
W Association between prostate cancer occurrence
and Y-chromosomal STRs.
M. Miri Nargesi, A. Nazemi, P.
Amini, P. Ismail, R. Vasudevan, P. Pasalar, A. H. Abdul Razack.
1084
T The clinical phenotype of endometrial cancer in
women of Newfoundland and Labrador with a
MSH2
Lynch syndrome mutation.
A. H. G. Nichols, L. M.
Dawson, J. Green, E. Dicks, P. Parfrey.
1085
F A unique African prostate cancer cohort to
investigate genetic and environmental risk factors of